Dennis Falzon
- Multidrug-resistant tuberculosis in children: evidence from global surveillanceBy Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara and Katherine FloydMatteo Zignol1STOP TB Dept, World Health Organization, Geneva, SwitzerlandCharalambos Sismanidis1STOP TB Dept, World Health Organization, Geneva, SwitzerlandDennis Falzon1STOP TB Dept, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1STOP TB Dept, World Health Organization, Geneva, SwitzerlandMasoud Dara2TB and M/XDR-TB Programme, World Health Organization Regional Office for Europe, Copenhagen, DenmarkKatherine Floyd1STOP TB Dept, World Health Organization, Geneva, Switzerland
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesBy Dennis Falzon, Neel Gandhi, Giovanni B. Migliori, Giovanni Sotgiu, Helen S. Cox, Timothy H. Holtz, Maria-Graciela Hollm-Delgado, Salmaan Keshavjee, Kathryn DeRiemer, Rosella Centis, Lia D'Ambrosio, Christoph G. Lange, Melissa Bauer and Dick MenziesDennis Falzon1Stop TB Dept, World Health Organization, Geneva, SwitzerlandNeel Gandhi2Divisions of General Internal Medicine, Infectious Diseases and Epidemiology, Albert Einstein College of Medicine, New York, NYGiovanni B. Migliori3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateGiovanni Sotgiu4Dept of Biomedical Sciences, University of Sassari, Sassari, ItalyHelen S. Cox5Médecins Sans Frontières, Cape Town, South AfricaTimothy H. Holtz6US Centers for Disease Control and Prevention, HIV/STD Research Program, Bangkok, ThailandMaria-Graciela Hollm-Delgado7Montreal Chest Institute, McGill University, Montreal, QC, CanadaSalmaan Keshavjee8Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MAKathryn DeRiemer9School of Medicine, University of California Davis, Davis, CA, USARosella Centis3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateLia D'Ambrosio3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateChristoph G. Lange10Clinical Infectious Diseases, Tuberculosis Center Borstel, Borstel, GermanyMelissa Bauer7Montreal Chest Institute, McGill University, Montreal, QC, Canada11Dept of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QCDick Menzies7Montreal Chest Institute, McGill University, Montreal, QC, Canada
- Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysisBy Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi, Dennis Falzon, Kathryn DeRiemer, Rosella Centis, Maria-Graciela Hollm-Delgado, Domingo Palmero, Carlos Pérez-Guzmán, Mario H. Vargas, Lia D'Ambrosio, Antonio Spanevello, Melissa Bauer, Edward D. Chan, H. Simon Schaaf, Salmaan Keshavjee, Timothy H. Holtz, Dick Menzies and The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TBGiovanni Battista Migliori1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate15Both authors contributed equallyGiovanni Sotgiu2Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari15Both authors contributed equallyNeel R. Gandhi3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NYDennis Falzon4Stop TB Dept, World Health Organization, Geneva, SwitzerlandKathryn DeRiemer5School of Medicine, University of California Davis, Davis, CARosella Centis1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMaria-Graciela Hollm-Delgado6Montreal Chest Institute, McGill University, Montreal, QC, CanadaDomingo Palmero7Pulmonology Division, Hospital F. J. Muñiz, Buenos Aires, ArgentinaCarlos Pérez-Guzmán8Instituto de Servicios de Salud del Estado de Aguascalientes, Unidad de Medicina Ambulatoria Aguascalientes, Instituto Mexicano del Seguro Social, AguascalientesMario H. Vargas9Instituto Nacional de Enfermedades Respiratorias, and Medical Research Unit in Respiratory Diseases, Instituto Mexicano del Seguro Social, Mexico City, MexicoLia D'Ambrosio1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateAntonio Spanevello10Università degli Studi dell’ Insubria, Varese and Division of Pneumology, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMelissa Bauer6Montreal Chest Institute, McGill University, Montreal, QC, CanadaEdward D. Chan11Pulmonary Dept, Denver Veterans Affair Medical Center and National Jewish Health, Denver, COH. Simon Schaaf12Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South AfricaSalmaan Keshavjee13Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MATimothy H. Holtz14Centers for Disease Control and Prevention, Atlanta, GA, USADick Menzies6Montreal Chest Institute, McGill University, Montreal, QC, Canada16A full list of the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB members can be found in the Acknowledgements section
- Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIFBy Karin Weyer, Fuad Mirzayev, Giovanni Battista Migliori, Wayne Van Gemert, Lia D'Ambrosio, Matteo Zignol, Katherine Floyd, Rosella Centis, Daniela M. Cirillo, Enrico Tortoli, Chris Gilpin, Jean de Dieu Iragena, Dennis Falzon and Mario RaviglioneKarin Weyer1Stop TB Dept, World Health Organization, Geneva, SwitzerlandFuad Mirzayev1Stop TB Dept, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateWayne Van Gemert1Stop TB Dept, World Health Organization, Geneva, SwitzerlandLia D'Ambrosio2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMatteo Zignol1Stop TB Dept, World Health Organization, Geneva, SwitzerlandKatherine Floyd1Stop TB Dept, World Health Organization, Geneva, SwitzerlandRosella Centis2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateDaniela M. Cirillo3Emerging Pathogens Unit TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, ItalyEnrico Tortoli3Emerging Pathogens Unit TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, ItalyChris Gilpin1Stop TB Dept, World Health Organization, Geneva, SwitzerlandJean de Dieu Iragena1Stop TB Dept, World Health Organization, Geneva, SwitzerlandDennis Falzon1Stop TB Dept, World Health Organization, Geneva, SwitzerlandMario Raviglione1Stop TB Dept, World Health Organization, Geneva, Switzerland
- The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosisBy Dennis Falzon, Ernesto Jaramillo and Holger SchünemannDennis Falzon1Stop TB Department, World Health Organisation (WHO), Geneva, SwitzerlandErnesto Jaramillo1Stop TB Department, World Health Organisation (WHO), Geneva, SwitzerlandHolger Schünemann2Department of Clinical Epidemiology & Biostatistics, McMaster University Health Sciences Centre, Hamilton, Canada
- HIV and multidrug-resistant tuberculosis: overlapping epidemicsBy Anna S. Dean, Matteo Zignol, Dennis Falzon, Haileyesus Getahun and Katherine FloydAnna S. DeanGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandMatteo ZignolGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandDennis FalzonGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandHaileyesus GetahunGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandKatherine FloydGlobal Tuberculosis Programme, World Health Organization, Geneva, Switzerland
- Time trends in multidrug-resistant tuberculosisBy Matteo Zignol and Dennis FalzonMatteo Zignol1STOP TB Department, World Health Organization, Geneva, SwitzerlandDennis Falzon1STOP TB Department, World Health Organization, Geneva, Switzerland
- Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemicsBy Matteo Zignol, Dennis Falzon and Dara MasoudMatteo Zignol1STOP TB Department, World Health Organization, Geneva, SwitzerlandDennis Falzon1STOP TB Department, World Health Organization, Geneva, SwitzerlandDara Masoud2Regional Office for Europe, World Health Organization, Copenhagen, Denmark
- Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis careBy Shanthi N. Pal, Christian Lienhardt, Sten Olsson and Dennis FalzonShanthi N. Pal2Department of Essential Medicines and Pharmaceutical Policies, World Health Organization, Geneva, SwitzerlandChristian Lienhardt1STOP TB Department, World Health Organization, Geneva, SwitzerlandSten Olsson3The Uppsala Monitoring Centre, (UMC), Uppsala, SwedenDennis Falzon1STOP TB Department, World Health Organization, Geneva, Switzerland
- Is multidrug-resistant TB more common in children? An analysis of surveillance dataBy Matteo Zignol, Charalambos Sismanidis, Dennis Falzon and Philippe GlaziouMatteo Zignol1STOP TB Department, World Health Organization, Geneva, SwitzerlandCharalambos Sismanidis1STOP TB Department, World Health Organization, Geneva, SwitzerlandDennis Falzon1STOP TB Department, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1STOP TB Department, World Health Organization, Geneva, Switzerland
- Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countriesBy Dennis Falzon, Matteo Zignol, Ernesto Jaramillo, Fraser Wares, Susanne Carai, Tauhid Islam and Paul NunnDennis Falzon1STOP TB, World Health Organization, Geneva, SwitzerlandMatteo Zignol1STOP TB, World Health Organization, Geneva, SwitzerlandErnesto Jaramillo1STOP TB, World Health Organization, Geneva, SwitzerlandFraser Wares1STOP TB, World Health Organization, Geneva, SwitzerlandSusanne Carai1STOP TB, World Health Organization, Geneva, SwitzerlandTauhid Islam1STOP TB, World Health Organization, Geneva, SwitzerlandPaul Nunn1STOP TB, World Health Organization, Geneva, Switzerland
- Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus - 2009-2010By Alena Skrahina, Andrei Khaliaukin, Dennis Falzon, Valiantsin Rusovich, Masoud Dara, Aliaksandr Shyrayeu, Liudmila Zhylevich, Matteo Zignol and Hennadz HurevichAlena Skrahina1Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusAndrei Khaliaukin2Gomel Regional Tuberculosis Hospital, Gomel, BelarusDennis Falzon3STOP TB Department, World Health Organization, Geneva, SwitzerlandValiantsin Rusovich4Country Office, World Health Organization, Minsk, BelarusMasoud Dara5Regional Office for Europe, World Health Organization, Copenhagen, DenmarkAliaksandr Shyrayeu2Gomel Regional Tuberculosis Hospital, Gomel, BelarusLiudmila Zhylevich6General Directorate of Medical Care, Ministry of Health, Minsk, BelarusMatteo Zignol3STOP TB Department, World Health Organization, Geneva, SwitzerlandHennadz Hurevich1Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus
- Getting the best possible evidence from observational studies of treatment of multidrug-resistant tuberculosis patientsBy Dennis Falzon, Richard (Dick) Menzies, Charles L. Daley, Christian Lienhardt, Aamir Khan, Michael L. Rich, Mohammed A. Aziz, Catharina S.B. van Weezenbeek and Carole D. MitnickDennis Falzon1Stop TB Department, World Health Organization, Geneva, SwitzerlandRichard (Dick) Menzies2Montreal Chest Institute, McGill University, Montréal, CanadaCharles L. Daley3Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, United StatesChristian Lienhardt1Stop TB Department, World Health Organization, Geneva, SwitzerlandAamir Khan4Interactive Research and Development, The Indus Hospital, Karachi, PakistanMichael L. Rich5Partners in Health, PIH, Boston, United StatesMohammed A. Aziz6Regional Office for the Eestern Mediterranean, World Health Organization, Cairo, EgyptCatharina S.B. van Weezenbeek7Regional Office for the Western Pacific, World Health Organization, Manila, PhilippinesCarole D. Mitnick5Partners in Health, PIH, Boston, United States8Department of Global Health & Social Medicine, Harvard Medical School, Boston, United States
- Multidrug-resistant tuberculosis in children: evidence from global surveillanceBy Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara and Katherine FloydArticle | Published in 2012 in European Respiratory JournalMatteo Zignol*STOP TB Dept, World Health Organization, Geneva, SwitzerlandCharalambos Sismanidis*STOP TB Dept, World Health Organization, Geneva, SwitzerlandDennis Falzon*STOP TB Dept, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou*STOP TB Dept, World Health Organization, Geneva, SwitzerlandMasoud Dara#TB and M/XDR-TB Programme, World Health Organization Regional Office for Europe, Copenhagen, DenmarkKatherine Floyd*STOP TB Dept, World Health Organization, Geneva, Switzerland
- HIV and multidrug-resistant tuberculosis: overlapping epidemicsBy Anna S. Dean, Matteo Zignol, Dennis Falzon, Haileyesus Getahun and Katherine FloydArticle | Published in 2014 in European Respiratory JournalAnna S. DeanGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandMatteo ZignolGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandDennis FalzonGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandHaileyesus GetahunGlobal Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandKatherine FloydGlobal Tuberculosis Programme, World Health Organization, Geneva, Switzerland
- Multidrug-resistant tuberculosis in children: evidence from global surveillanceBy Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara and Katherine FloydArticle | Published in 2012 in European Respiratory JournalMatteo Zignol*STOP TB Dept, World Health Organization, Geneva, SwitzerlandCharalambos Sismanidis*STOP TB Dept, World Health Organization, Geneva, SwitzerlandDennis Falzon*STOP TB Dept, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou*STOP TB Dept, World Health Organization, Geneva, SwitzerlandMasoud Dara#TB and M/XDR-TB Programme, World Health Organization Regional Office for Europe, Copenhagen, DenmarkKatherine Floyd*STOP TB Dept, World Health Organization, Geneva, Switzerland
- Multidrug-resistant tuberculosis around the world: what progress has been made?By Dennis Falzon, Fuad Mirzayev, Fraser Wares, Inés Garcia Baena, Matteo Zignol, Nguyen Linh, Karin Weyer, Ernesto Jaramillo, Katherine Floyd and Mario RaviglioneArticle | Published in 2014 in European Respiratory JournalDennis FalzonGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFuad MirzayevGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFraser WaresGlobal TB Programme, World Health Organization, Geneva, SwitzerlandInés Garcia BaenaGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMatteo ZignolGlobal TB Programme, World Health Organization, Geneva, SwitzerlandNguyen LinhGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKarin WeyerGlobal TB Programme, World Health Organization, Geneva, SwitzerlandErnesto JaramilloGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKatherine FloydGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMario RaviglioneGlobal TB Programme, World Health Organization, Geneva, Switzerland
- Multidrug-resistant tuberculosis around the world: what progress has been made?By Dennis Falzon, Fuad Mirzayev, Fraser Wares, Inés Garcia Baena, Matteo Zignol, Nguyen Linh, Karin Weyer, Ernesto Jaramillo, Katherine Floyd and Mario RaviglioneArticle | Published in 2014 in European Respiratory JournalDennis FalzonGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFuad MirzayevGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFraser WaresGlobal TB Programme, World Health Organization, Geneva, SwitzerlandInés Garcia BaenaGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMatteo ZignolGlobal TB Programme, World Health Organization, Geneva, SwitzerlandNguyen LinhGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKarin WeyerGlobal TB Programme, World Health Organization, Geneva, SwitzerlandErnesto JaramilloGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKatherine FloydGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMario RaviglioneGlobal TB Programme, World Health Organization, Geneva, Switzerland
- Drug resistance and tuberculosis elimination in low-incidence countriesBy Dennis Falzon, Jean-Pierre Zellweger, Giovanni Battista Migliori and Ernesto JaramilloDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger2Swiss Lung Association, Berne, SwitzerlandGiovanni Battista Migliori3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyErnesto Jaramillo1Global TB Programme, World Health Organization, Geneva, Switzerland
- Multidrug-resistant tuberculosis around the world: what progress has been made?By Dennis Falzon, Fuad Mirzayev, Fraser Wares, Inés Garcia Baena, Matteo Zignol, Nguyen Linh, Karin Weyer, Ernesto Jaramillo, Katherine Floyd and Mario RaviglioneDennis FalzonGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFuad MirzayevGlobal TB Programme, World Health Organization, Geneva, SwitzerlandFraser WaresGlobal TB Programme, World Health Organization, Geneva, SwitzerlandInés Garcia BaenaGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMatteo ZignolGlobal TB Programme, World Health Organization, Geneva, SwitzerlandNguyen LinhGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKarin WeyerGlobal TB Programme, World Health Organization, Geneva, SwitzerlandErnesto JaramilloGlobal TB Programme, World Health Organization, Geneva, SwitzerlandKatherine FloydGlobal TB Programme, World Health Organization, Geneva, SwitzerlandMario RaviglioneGlobal TB Programme, World Health Organization, Geneva, Switzerland
- The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)By Luciana Brondi, Dennis Falzon, Charalambos Sismanidis, Philippe Glaziou, Matteo Zignol, Katherine Floyd, Harry Campbell and Harish NairLuciana Brondi1Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, Scotland, United KingdomDennis Falzon2Global TB Programme, World Health Organization, Geneva, SwitzerlandCharalambos Sismanidis2Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou2Global TB Programme, World Health Organization, Geneva, SwitzerlandMatteo Zignol2Global TB Programme, World Health Organization, Geneva, SwitzerlandKatherine Floyd2Global TB Programme, World Health Organization, Geneva, SwitzerlandHarry Campbell1Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, Scotland, United KingdomHarish Nair1Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, Scotland, United Kingdom
- Geographic origin and other determinants of site of tuberculosis disease in European countriesBy Nicolas Lefebvre, Dennis Falzon, Vahur Hollo, Marieke van der Werf, Andreas Sandgren and Giovanni SotgiuNicolas Lefebvre1Service des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires de Strasbourg, Strasbourg, FranceDennis Falzon2Global TB Programme, World Health Organization, Geneva, SwitzerlandVahur Hollo3European Centre for Disease Prevention and Control, (ECDC), Stockholm, SwedenMarieke van der Werf3European Centre for Disease Prevention and Control, (ECDC), Stockholm, SwedenAndreas Sandgren3European Centre for Disease Prevention and Control, (ECDC), Stockholm, SwedenGiovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of BioMedical Sciences, University of Sassari (Research, Medical Education and Professional Development Unit), Sassari, Italy
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneArticle | Published in 2015 in European Respiratory JournalKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- The role of eHealth and mHealth in tuberculosis and tobacco control: a WHO/ERS consultationBy Dennis Falzon, Mario Raviglione, Elisabeth H. Bel, Christina Gratziou, Douglas Bettcher and Giovanni Battista MiglioriDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMario Raviglione1Global TB Programme, World Health Organization, Geneva, SwitzerlandElisabeth H. Bel2European Respiratory Society, Lausanne, SwitzerlandChristina Gratziou2European Respiratory Society, Lausanne, SwitzerlandDouglas Bettcher3Department for Prevention of Non-communicable Diseases, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori2European Respiratory Society, Lausanne, Switzerland4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesBy Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Mohamed Abdel Aziz, Annabel Baddeley, Draurio Barreira, Saskia Den Boon, Susana Marta Borroto Gutierrez, Judith Bruchfeld, Erlina Burhan, Solange Cavalcante, Rolando Cedillos, Richard Chaisson, Cynthia Bin-Eng Chee, Lucy Chesire, Elizabeth Corbett, Masoud Dara, Justin Denholm, Gerard de Vries, Dennis Falzon, Nathan Ford, Margaret Gale-Rowe, Chris Gilpin, Enrico Girardi, Un-Yeong Go, Darshini Govindasamy, Alison D. Grant, Malgorzata Grzemska, Ross Harris, C. Robert Horsburgh, Asker Ismayilov, Ernesto Jaramillo, Sandra Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng Xheedha Rangaka, Andreas Reis, Lisa Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender Kumar Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf-Schouten, Diana Weil, Karin Weyer, Robert John Wilkinson, Takashi Yoshiyama, Jean Pierre Zellweger and Mario RaviglioneArticle | Published in 2015 in European Respiratory JournalHaileyesus Getahun1The Global TB Programme, World Health Organization, Geneva, SwitzerlandAlberto Matteelli1The Global TB Programme, World Health Organization, Geneva, SwitzerlandIbrahim Abubakar2Dept of Infection and Population Health, University College London, London, UK3Public Health England, London, UKMohamed Abdel Aziz4World Health Organization, Regional Office for Eastern Mediterranean, EgyptAnnabel Baddeley1The Global TB Programme, World Health Organization, Geneva, SwitzerlandDraurio Barreira5National TB Programme, Ministry of Health, Brasilia, BrazilSaskia Den Boon6Independent consultant, SwitzerlandSusana Marta Borroto Gutierrez7Pedro Kourí Institute of Tropical Medicine, La Habana, CubaJudith Bruchfeld8Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenErlina Burhan9Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, IndonesiaSolange Cavalcante10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, BrazilRolando Cedillos11Hospital Nacionale Rosales, San Salvador, El SalvadorRichard Chaisson12Center for TB Research, John Hopkins University, Baltimore, MD, USACynthia Bin-Eng Chee13Tan Tock Seng Hospital, SingaporeLucy Chesire14TB Advocacy Consortium, Nairobi, KenyaElizabeth Corbett15London School of Hygiene and Tropical Medicine, Blantyre, MalawiMasoud Dara16World Health Organization, Regional Office for Europe, DenmarkJustin Denholm17Victorian Tuberculosis Program, Melbourne, AustraliaGerard de Vries18KNCV Tuberculosis Foundation, Den Haag, The NetherlandsDennis Falzon1The Global TB Programme, World Health Organization, Geneva, SwitzerlandNathan Ford19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandMargaret Gale-Rowe20Public Health Agency of Canada, Ottawa, ON, CanadaChris Gilpin1The Global TB Programme, World Health Organization, Geneva, SwitzerlandEnrico Girardi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyUn-Yeong Go22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of KoreaDarshini Govindasamy23Health Systems Research Unit, South African Medical Research Council, South AfricaAlison D. Grant24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKMalgorzata Grzemska1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRoss Harris3Public Health England, London, UKC. Robert Horsburgh Jr.25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USAAsker Ismayilov26Main Medical Department, Ministry of Justice, AzerbaijanErnesto Jaramillo1The Global TB Programme, World Health Organization, Geneva, SwitzerlandSandra Kik27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaKatharina Kranzer24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKChristian Lienhardt1The Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilip LoBue28Centers for Disease Control and Prevention, USAKnut Lönnroth1The Global TB Programme, World Health Organization, Geneva, Switzerland29Dept of Public Health Sciences, Karolinska Institute, Solna, SwedenGuy Marks30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, AustraliaDick Menzies27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaGiovanni Battista Migliori31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyDavide Mosca32Migration Health Department, International Organization of Migration, Geneva, SwitzerlandYa Diul Mukadi33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USAAlwyn Mwinga34Zambart Project, Lusaka, ZambiaLisa Nelson19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandNobuyuki Nishikiori35World Health Organization, Regional Office for the Western Pacific, PhilippinesAnouk Oordt-Speets36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsMolebogeng Xheedha Rangaka2Dept of Infection and Population Health, University College London, London, UK37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South AfricaAndreas Reis38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandLisa Rotz28Centers for Disease Control and Prevention, USAAndreas Sandgren39European Centre for Disease Prevention and Control, Stockholm, SwedenMonica Sañé Schepisi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyHolger J. Schünemann40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, CanadaSurender Kumar Sharma38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandGiovanni Sotgiu39European Centre for Disease Prevention and Control, Stockholm, SwedenHelen R. Stagg2Dept of Infection and Population Health, University College London, London, UKTimothy R. Sterling43Vanderbilt University School of Medicine, Nashville, TN, USATamara Tayeb44National TB Programme, Ministry of Health, Riyadh, Saudi ArabiaMukund Uplekar1The Global TB Programme, World Health Organization, Geneva, SwitzerlandMarieke J. van der Werf39European Centre for Disease Prevention and Control, Stockholm, SwedenWim Vandevelde45European AIDS Treatment Group, Brussels, BelgiumFemke van Kessel36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsAnna van't Hoog46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The NetherlandsJay K. Varma28Centers for Disease Control and Prevention, USANatalia Vezhnina47HIV/TB and Penal System Projects, Russian FederationConstantia Voniatis48Clinical Laboratories, Ministry of Health, Nicosia, CyprusMarije Vonk Noordegraaf-Schouten36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsDiana Weil1The Global TB Programme, World Health Organization, Geneva, SwitzerlandKarin Weyer1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRobert John Wilkinson37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UKTakashi Yoshiyama50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, JapanJean Pierre Zellweger51Tuberculosis Competence Centre, Berne, SwitzerlandMario Raviglione1The Global TB Programme, World Health Organization, Geneva, Switzerland
- Joint WHO/ERS initiative on e-/m-Health for TB and tobacco controlBy Dennis Falzon, Mario Raviglione, Douglas Bettcher, Dongbo Fu, Giovannibattista Migliori, Christina Gratziou and Elisabeth H. BelDennis Falzon1Global TB Programme, World Health Organization (WHO), Geneva, SwitzerlandMario Raviglione1Global TB Programme, World Health Organization (WHO), Geneva, SwitzerlandDouglas Bettcher2Department for Prevention of Non-Communicable Diseases, World Health Organization (WHO), Geneva, SwitzerlandDongbo Fu2Department for Prevention of Non-Communicable Diseases, World Health Organization (WHO), Geneva, SwitzerlandGiovannibattista Migliori3European Respiratory Society, ERS, Lausanne, SwitzerlandChristina Gratziou3European Respiratory Society, ERS, Lausanne, SwitzerlandElisabeth H. Bel3European Respiratory Society, ERS, Lausanne, Switzerland
- Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015By Alena Skrahina, Hennadz Hurevich, Dennis Falzon, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, George Sakvarelidze and Svetlana SetkinaAlena Skrahina1Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, Ministry of Health, Minsk, BelarusHennadz Hurevich1Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, Ministry of Health, Minsk, BelarusDennis Falzon2Global TB Programme, World Health Organization (WHO), Geneva, SwitzerlandLiudmila Zhylevich3General Directorate of Medical Care, Ministry of Health, Minsk, BelarusValiantsin Rusovich4Country Office, World Health Organization (WHO), Minsk, BelarusMasoud Dara5Regional Office for Europe, World Health Organization (WHO), Copenhagen, DenmarkAndrei Dadu5Regional Office for Europe, World Health Organization (WHO), Copenhagen, DenmarkGeorge Sakvarelidze6The Global Fund to Fight AIDS, Tuberculosis and Malaria, GFATM, Geneva, SwitzerlandSvetlana Setkina7Centre for Examinations and Tests in Health Care, Ministry of Health, Minsk, Belarus
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesBy Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Mohamed Abdel Aziz, Annabel Baddeley, Draurio Barreira, Saskia Den Boon, Susana Marta Borroto Gutierrez, Judith Bruchfeld, Erlina Burhan, Solange Cavalcante, Rolando Cedillos, Richard Chaisson, Cynthia Bin-Eng Chee, Lucy Chesire, Elizabeth Corbett, Masoud Dara, Justin Denholm, Gerard de Vries, Dennis Falzon, Nathan Ford, Margaret Gale-Rowe, Chris Gilpin, Enrico Girardi, Un-Yeong Go, Darshini Govindasamy, Alison D. Grant, Malgorzata Grzemska, Ross Harris, C. Robert Horsburgh Jr, Asker Ismayilov, Ernesto Jaramillo, Sandra Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng Xheedha Rangaka, Andreas Reis, Lisa Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender Kumar Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf-Schouten, Diana Weil, Karin Weyer, Robert John Wilkinson, Takashi Yoshiyama, Jean Pierre Zellweger and Mario RaviglioneHaileyesus Getahun1The Global TB Programme, World Health Organization, Geneva, SwitzerlandAlberto Matteelli1The Global TB Programme, World Health Organization, Geneva, SwitzerlandIbrahim Abubakar2Dept of Infection and Population Health, University College London, London, UK3Public Health England, London, UKMohamed Abdel Aziz4World Health Organization, Regional Office for Eastern Mediterranean, EgyptAnnabel Baddeley1The Global TB Programme, World Health Organization, Geneva, SwitzerlandDraurio Barreira5National TB Programme, Ministry of Health, Brasilia, BrazilSaskia Den Boon6Independent consultant, SwitzerlandSusana Marta Borroto Gutierrez7Pedro Kourí Institute of Tropical Medicine, La Habana, CubaJudith Bruchfeld8Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenErlina Burhan9Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, IndonesiaSolange Cavalcante10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, BrazilRolando Cedillos11Hospital Nacionale Rosales, San Salvador, El SalvadorRichard Chaisson12Center for TB Research, John Hopkins University, Baltimore, MD, USACynthia Bin-Eng Chee13Tan Tock Seng Hospital, SingaporeLucy Chesire14TB Advocacy Consortium, Nairobi, KenyaElizabeth Corbett15London School of Hygiene and Tropical Medicine, Blantyre, MalawiMasoud Dara16World Health Organization, Regional Office for Europe, DenmarkJustin Denholm17Victorian Tuberculosis Program, Melbourne, AustraliaGerard de Vries18KNCV Tuberculosis Foundation, Den Haag, The NetherlandsDennis Falzon1The Global TB Programme, World Health Organization, Geneva, SwitzerlandNathan Ford19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandMargaret Gale-Rowe20Public Health Agency of Canada, Ottawa, ON, CanadaChris Gilpin1The Global TB Programme, World Health Organization, Geneva, SwitzerlandEnrico Girardi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyUn-Yeong Go22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of KoreaDarshini Govindasamy23Health Systems Research Unit, South African Medical Research Council, South AfricaAlison D. Grant24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKMalgorzata Grzemska1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRoss Harris3Public Health England, London, UKC. Robert Horsburgh Jr25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USAAsker Ismayilov26Main Medical Department, Ministry of Justice, AzerbaijanErnesto Jaramillo1The Global TB Programme, World Health Organization, Geneva, SwitzerlandSandra Kik27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaKatharina Kranzer24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKChristian Lienhardt1The Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilip LoBue28Centers for Disease Control and Prevention, USAKnut Lönnroth1The Global TB Programme, World Health Organization, Geneva, Switzerland29Dept of Public Health Sciences, Karolinska Institute, Solna, SwedenGuy Marks30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, AustraliaDick Menzies27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaGiovanni Battista Migliori31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyDavide Mosca32Migration Health Department, International Organization of Migration, Geneva, SwitzerlandYa Diul Mukadi33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USAAlwyn Mwinga34Zambart Project, Lusaka, ZambiaLisa Nelson19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandNobuyuki Nishikiori35World Health Organization, Regional Office for the Western Pacific, PhilippinesAnouk Oordt-Speets36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsMolebogeng Xheedha Rangaka2Dept of Infection and Population Health, University College London, London, UK37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South AfricaAndreas Reis38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandLisa Rotz28Centers for Disease Control and Prevention, USAAndreas Sandgren39European Centre for Disease Prevention and Control, Stockholm, SwedenMonica Sañé Schepisi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyHolger J. Schünemann40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, CanadaSurender Kumar Sharma38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandGiovanni Sotgiu39European Centre for Disease Prevention and Control, Stockholm, SwedenHelen R. Stagg2Dept of Infection and Population Health, University College London, London, UKTimothy R. Sterling43Vanderbilt University School of Medicine, Nashville, TN, USATamara Tayeb44National TB Programme, Ministry of Health, Riyadh, Saudi ArabiaMukund Uplekar1The Global TB Programme, World Health Organization, Geneva, SwitzerlandMarieke J. van der Werf39European Centre for Disease Prevention and Control, Stockholm, SwedenWim Vandevelde45European AIDS Treatment Group, Brussels, BelgiumFemke van Kessel36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsAnna van't Hoog46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The NetherlandsJay K. Varma28Centers for Disease Control and Prevention, USANatalia Vezhnina47HIV/TB and Penal System Projects, Russian FederationConstantia Voniatis48Clinical Laboratories, Ministry of Health, Nicosia, CyprusMarije Vonk Noordegraaf-Schouten36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsDiana Weil1The Global TB Programme, World Health Organization, Geneva, SwitzerlandKarin Weyer1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRobert John Wilkinson37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UKTakashi Yoshiyama50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, JapanJean Pierre Zellweger51Tuberculosis Competence Centre, Berne, SwitzerlandMario Raviglione1The Global TB Programme, World Health Organization, Geneva, Switzerland
- Numbers needed to treat to prevent tuberculosisBy Alberto Matteelli, Knut Lönnroth, Haileyesus Getahun, Dennis Falzon, Giovanni Battista Migliori and Mario RaviglioneAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, SwitzerlandHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMario Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.